Press "Enter" to skip to content

COVID-19 vaccine Surplus May Be Due to Hesitancy

There is an increasing COVID-19 vaccine surplus across the world, and although many have been waiting for those terms, there is concern that the United States may not achieve herd immunity as quickly as originally expected.

Despite this, doctors continue to recommend that anyone who is willing to get vaccinated against the virus do so. More than 225 million Americans had received at least one dose, as of Sunday morning, with around a fifth of the population being completely vaccinated. People missing their second dose of COVID-19 vaccine, on the other hand, is becoming a problem that some health experts are noticing.

The rise in missed second COVID-19 vaccine doses was expected with the increase in eligibility. However, top health officials are now working on determining why this is the case. Doctors and experts are concerned about the long-term implications for the millions who do not get the second shot. Research is underway of how this would affect herd immunity in the fight against COVID-19.

Only 92 percent of people are completing the two-dose series of Pfizer and Moderna vaccines, according to new data from the Centers for Disease Control. This suggests that about 8% of those who were eligible for the second dose could have missed it. This 8% equates to approximately 5 million Americans.

A clinical immunologist, Dr. Zachary Rubin, said, “That means that we’re not going to be able to reach herd immunity as quickly as we would like.” Officials are now informing those who have skipped their second dose that it is needed for full immunity and to be considered completely vaccinated.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *